Colgate-Palmolive (CL) Stock Forecast & Price Target

$91.96 +0.22 (+0.24%)

As of 03:59 PM Eastern

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 20 Analyst Ratings

Sell
1

Hold
9

Buy
10

Based on 20 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Hold." Out of the 20 analysts, 1 has given a sell rating, 9 have given a hold rating, and 10 have given a buy rating for CL.

Consensus Price Target

$102.12
11.05% Upside

According to the 20 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $102.12. The highest price target for CL is $110.00, while the lowest price target for CL is $86.00. The average price target represents a forecasted upside of 11.05% from the current price of $91.96.

Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

CL Analyst Ratings Over Time

Type	Current Forecast 5/20/24 to 5/20/25	1 Month Ago 4/20/24 to 4/20/25	3 Months Ago 2/20/24 to 2/19/25	1 Year Ago 5/21/23 to 5/20/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	11 Buy rating(s)	12 Buy rating(s)	13 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$102.12	$102.17	$101.16	$92.35
Forecasted Upside	11.05% Upside	6.99% Upside	15.85% Upside	-2.18% Downside
Consensus Rating	Hold	Hold	Moderate Buy	Moderate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.45	2.54	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	11.30% Upside	47.26% Upside	12.81% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/28/2025	Citigroup 3 of 5 stars	Filippo Falorni Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$103.00 ➝ $108.00	+18.78%
4/28/2025	JPMorgan Chase & Co. 2 of 5 stars	Andrea Teixeira Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$95.00 ➝ $103.00	+12.05%
4/17/2025	UBS Group 3 of 5 stars	Peter Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$105.00 ➝ $109.00	+14.69%
4/11/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lauren Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$89.00 ➝ $86.00	-8.50%
4/2/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Underweight ➝ Underweight	$83.00 ➝ $88.00	-5.90%
3/31/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Korinne Wolfmeyer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$108.00 ➝ $107.00	+15.39%
2/3/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Astrachan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$95.00 ➝ $93.00	+7.86%
2/3/2025	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Olivia Tong Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$110.00 ➝ $105.00	+21.20%
2/3/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$111.00 ➝ $104.00	+20.04%
1/29/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$101.00 ➝ $101.00	+12.10%
Get the Latest News and Ratings for CL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.
1/8/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$110.00 ➝ $100.00	+14.53%
9/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$107.00 ➝ $109.00	+1.06%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
7/30/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$100.00 ➝ $103.00	+3.00%
7/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Zamacona Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$103.00 ➝ $95.00	-1.61%
7/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $106.00	+6.91%
7/10/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+13.26%
6/24/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Grundy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$109.00	+12.06%
5/15/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Graja Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$97.00 ➝ $107.00	+13.01%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$93.00	+7.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:20 PM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, May 19, 2025. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

The current stock price is around $91.26, which may present a buying opportunity for investors looking for value.
Colgate-Palmolive recently reported earnings per share of $0.91, exceeding analysts' expectations, indicating strong financial performance.
The company has a robust return on equity of 477.77%, suggesting effective management and profitability relative to shareholder equity.
Colgate-Palmolive has increased its quarterly dividend to $0.52, reflecting a commitment to returning value to shareholders and a healthy dividend yield of 2.28%.
The board has approved a significant share buyback plan of $5.00 billion, which often signals that the company believes its stock is undervalued and can enhance shareholder value.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

The company's revenue for the latest quarter was down 3.0% year-over-year, which may indicate challenges in maintaining sales growth.
Colgate-Palmolive has a relatively high debt-to-equity ratio of 13.40, suggesting that the company relies heavily on debt financing, which can be risky in volatile markets.
The price-to-earnings ratio of 25.93 may indicate that the stock is overvalued compared to its earnings, which could deter value-focused investors.
Analysts have a consensus rating of "Hold," suggesting that there may be uncertainty about the stock's future performance.
The company's quick ratio of 0.58 indicates potential liquidity issues, as it may struggle to meet short-term obligations without selling inventory.

CL Forecast - Frequently Asked Questions

: According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $102.12, with a high forecast of $110.00 and a low forecast of $86.00.
: 20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There is currently 1 sell rating, 9 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CL, but not buy additional shares or sell existing shares.
: According to analysts, Colgate-Palmolive's stock has a predicted upside of 11.05% based on their 12-month stock forecasts.
: Colgate-Palmolive has been rated by research analysts at Barclays, Citigroup, JPMorgan Chase & Co., Piper Sandler, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Colgate-Palmolive less than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Hold while the average consensus rating for "consumer staples" companies is Moderate Buy. Learn more on how CL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CL) was last updated on 5/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Stock Forecast & Price Target